{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T19:02:52Z","timestamp":1783191772035,"version":"3.54.6"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:00:00Z","timestamp":1778803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>In patients with a known diagnosis of lung cancer, a new intracranial space-occupying lesion is most frequently interpreted as a brain metastasis. However, distinguishing it from an independent double primary brain tumor is critical, as treatment strategies and prognoses differ substantially. We report a rare case of primary glioblastoma occurring approximately two years after surgery for anaplastic lymphoma kinase (ALK)-positive lung adenocarcinoma. A 63-year-old female underwent radical resection for stage IA lung adenocarcinoma (ALK-positive) and received adjuvant ensartinib. Two years postoperatively, brain magnetic resonance imaging (MRI) revealed a solitary lesion in the right centrum semiovale, which was clinically misdiagnosed as a brain metastasis. The patient was subsequently treated with lorlatinib combined with stereotactic radiotherapy. Despite these interventions, she developed progressive left-sided limb weakness, and imaging demonstrated continuous lesion progression. Subsequent surgical resection and pathological examination confirmed primary glioblastoma, strongly supporting a diagnosis of metachronous double primary cancers (DPCs). The patient died 10 months after the glioblastoma diagnosis. This case highlights that during long-term follow-up of patients with malignancies, a new intracranial lesions may warrant consideration of a second primary cancer (SPC), particularly when the treatment response is not consistent with the expected biology of the original tumor. Timely pathological confirmation and multidisciplinary review may help reduce diagnostic delay and improve treatment selection.<\/jats:p>","DOI":"10.3389\/fonc.2026.1837876","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T04:27:00Z","timestamp":1778819220000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Primary glioblastoma mimicking brain metastasis in ALK-positive lung adenocarcinoma: a case report and literature review"],"prefix":"10.3389","volume":"16","author":[{"given":"Mengyuan","family":"Li","sequence":"first","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, Taizhou Municipal Hospital (Taizhou University Affiliated Municipal Hospital), School of Medicine","place":["Taizhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanghuang","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Taizhou Municipal Hospital (Taizhou University Affiliated Municipal Hospital), School of Medicine","place":["Taizhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, Taizhou Municipal Hospital (Taizhou University Affiliated Municipal Hospital), School of Medicine","place":["Taizhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Taizhou Municipal Hospital (Taizhou University Affiliated Municipal Hospital), School of Medicine","place":["Taizhou, China"]},{"name":"Taizhou Key Laboratory of Sepsis, Taizhou Municipal Hospital","place":["Taizhou, China"]},{"name":"Taizhou Key Laboratory of Infection and Tumor Immunology, Taizhou Municipal Hospital","place":["Taizhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.21871","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J Clin"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2021.3523","article-title":"Ensartinib vs Crizotinib for patients with anaplastic lymphoma kinase-positive non-small cell lung cancer: A randomized clinical trial","volume":"7","author":"Horn","year":"2021","journal-title":"JAMA Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1200\/jco.24.00581","article-title":"Lorlatinib versus crizotinib in patients with advanced ALK-positive non-small cell lung cancer: 5-year outcomes from the phase III CROWN study","volume":"42","author":"Solomon","year":"2024","journal-title":"J Clin Oncol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.annonc.2025.09.018","article-title":"Alectinib versus crizotinib in previously untreated ALK-positive advanced non-small cell lung cancer: final overall survival analysis of the phase III ALEX study","volume":"37","author":"Peters","year":"2026","journal-title":"Ann Oncol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2025.108436","article-title":"Brain metastases and mortality in patients with ALK + metastatic non-small cell lung cancer treated with second-generation ALK tyrosine kinase inhibitors as first-line targeted therapies: An observational cohort study","volume":"201","author":"Uprety","year":"2025","journal-title":"Lung Cancer"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2025.108858","article-title":"Real-world incidence, prevalence, and clinical impact of brain metastases in patients with ALK-positive metastatic non-small cell lung cancer treated with first-line ALK tyrosine kinase inhibitors","volume":"212","author":"Liu","year":"2026","journal-title":"Lung Cancer"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3109\/07357909209032773","article-title":"Synchronous double Malignancy: adenocarcinoma of lung and Malignant astrocytoma induced by asbestos exposure","volume":"10","author":"Kishimoto","year":"1992","journal-title":"Cancer Invest"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2010.08.014","article-title":"Glioblastoma multiforme in a patient with a small cell lung cancer: case report","volume":"113","author":"Bari","year":"2011","journal-title":"Clin Neurol Neurosurg"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.0184-17","article-title":"Secondary brain neoplasm after stereotactic radiosurgery in patients with metastatic non-small cell lung cancer","volume":"57","author":"Nukaga","year":"2018","journal-title":"Intern Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1159\/000514297","article-title":"Co-occurrence conundrum: Brain metastases from lung adenocarcinoma, radiation necrosis, and gliosarcoma","volume":"14","author":"Qian","year":"2021","journal-title":"Case Rep Oncol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"CASE2171","DOI":"10.3171\/case21714","article-title":"Synchronous glioblastoma and brain metastases: illustrative case","volume":"3","author":"Shahsavari","year":"2022","journal-title":"J Neurosurg Case Lessons"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1159\/000543770","article-title":"Synchronous double primary Malignancy of non-small cell lung cancer and glioblastoma: A case report and literature review","volume":"18","author":"Carmicheal","year":"2025","journal-title":"Case Rep Oncol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.currproblcancer.2019.100530","article-title":"Tumor board report: The value of tissue diagnosis","volume":"44","author":"Hijab","year":"2020","journal-title":"Curr Probl Cancer"},{"key":"B15","doi-asserted-by":"publisher","first-page":"2960","DOI":"10.3390\/cancers13122960","article-title":"Differentiating glioblastomas from solitary brain metastases: An update on the current literature of advanced imaging modalities","volume":"13","author":"Fordham","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.12968\/hmed.2024.0195","article-title":"Ring-enhancing lesions-differentiation with MRI","volume":"85","author":"Peker","year":"2024","journal-title":"Br J Hosp Med (Lond)"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.3390\/diagnostics13142376","article-title":"A nomogram based on consolidation tumor ratio combined with solid or micropapillary patterns for postoperative recurrence in pathological stage IA lung adenocarcinoma","volume":"13","author":"Zhang","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.3390\/cancers17101696","article-title":"Spread through air spaces (STAS) as a predictive and prognostic factor in patients with non-small cell lung cancer-systematic review","volume":"17","author":"Herba","year":"2025","journal-title":"Cancers (Basel)"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1097\/jto.0000000000000486","article-title":"Tumor spread through air spaces is an important pattern of invasion and impacts the frequency and location of recurrences after limited resection for small stage I lung adenocarcinomas","volume":"10","author":"Kadota","year":"2015","journal-title":"J Thorac Oncol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1055\/s-0032-1330318","article-title":"Glioblastoma multiforme versus solitary supratentorial brain metastasis: differentiation based on morphology and magnetic resonance signal characteristics","volume":"185","author":"Maurer","year":"2013","journal-title":"Rofo"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.13677","article-title":"Solitary cerebral metastases vs. high-grade gliomas: Usefulness of two MRI signs in the differential diagnosis","volume":"39","author":"Muccio","year":"2019","journal-title":"Anticancer Res"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.29123","article-title":"Glioblastoma and solitary brain metastasis: Differentiation by integrating demographic-MRI and deep-learning radiomics signatures","volume":"60","author":"Zhang","year":"2024","journal-title":"J Magn Reson Imaging"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2024.111900","article-title":"Ensemble learning-based radiomics model for discriminating brain metastasis from glioblastoma","volume":"183","author":"Zeng","year":"2025","journal-title":"Eur J Radiol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctarc.2025.101040","article-title":"Artificial intelligence in glioblastoma diagnostics: Integrating MRI, histopathology, and molecular profiling","volume":"45","author":"Ahangari","year":"2025","journal-title":"Cancer Treat Res Commun"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2025.1581422","article-title":"Artificial intelligence in the task of segmentation and classification of brain metastases images: current challenges and future opportunities","volume":"16","author":"Hu","year":"2025","journal-title":"Front Neurol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s11060-014-1388-3","article-title":"Fractionated stereotactic radiosurgery for patients with brain metastases","volume":"117","author":"Minniti","year":"2014","journal-title":"J Neuro-Oncol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2024.09.008","article-title":"Molecular evolution of central nervous system metastasis and therapeutic implications","volume":"31","author":"Gritsch","year":"2025","journal-title":"Trends Mol Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtocrr.2023.100580","article-title":"Does multidisciplinary team management improve clinical outcomes in NSCLC? A systematic review with meta-analysis","volume":"4","author":"de Castro","year":"2023","journal-title":"JTO Clin Res Rep"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1837876\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T04:27:02Z","timestamp":1778819222000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1837876\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,15]]},"references-count":28,"alternative-id":["10.3389\/fonc.2026.1837876"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1837876","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,15]]},"article-number":"1837876"}}